CRVO
Price
$7.62
Change
+$0.08 (+1.06%)
Updated
Jun 6 closing price
Capitalization
65.62M
ONC
Price
$255.86
Change
-$1.14 (-0.44%)
Updated
Jun 6 closing price
Capitalization
29.26B
75 days until earnings call
Interact to see
Advertisement

CRVO vs ONC

Header iconCRVO vs ONC Comparison
Open Charts CRVO vs ONCBanner chart's image
CervoMed
Price$7.62
Change+$0.08 (+1.06%)
Volume$93.14K
Capitalization65.62M
BeOne Medicines
Price$255.86
Change-$1.14 (-0.44%)
Volume$402.22K
Capitalization29.26B
CRVO vs ONC Comparison Chart
Loading...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRVO vs. ONC commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRVO is a Buy and ONC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (CRVO: $7.87 vs. ONC: $240.41)
Brand notoriety: CRVO and ONC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRVO: 17% vs. ONC: 40%
Market capitalization -- CRVO: $65.62M vs. ONC: $29.26B
CRVO [@Biotechnology] is valued at $65.62M. ONC’s [@Biotechnology] market capitalization is $29.26B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRVO’s FA Score shows that 0 FA rating(s) are green whileONC’s FA Score has 0 green FA rating(s).

  • CRVO’s FA Score: 0 green, 5 red.
  • ONC’s FA Score: 0 green, 5 red.
According to our system of comparison, CRVO is a better buy in the long-term than ONC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRVO’s TA Score shows that 4 TA indicator(s) are bullish while ONC’s TA Score has 3 bullish TA indicator(s).

  • CRVO’s TA Score: 4 bullish, 4 bearish.
  • ONC’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, CRVO is a better buy in the short-term than ONC.

Price Growth

CRVO (@Biotechnology) experienced а -7.52% price change this week, while ONC (@Biotechnology) price change was +1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ONC is expected to report earnings on Aug 22, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ONC($29.3B) has a higher market cap than CRVO($65.6M). CRVO YTD gains are higher at: 236.325 vs. ONC (30.155). CRVO has higher annual earnings (EBITDA): -18.23M vs. ONC (-396.44M). ONC has more cash in the bank: 2.63B vs. CRVO (38.9M). CRVO has less debt than ONC: CRVO (0) vs ONC (1.08B). ONC has higher revenues than CRVO: ONC (3.81B) vs CRVO (0).
CRVOONCCRVO / ONC
Capitalization65.6M29.3B0%
EBITDA-18.23M-396.44M5%
Gain YTD236.32530.155784%
P/E Ratio4.73N/A-
Revenue03.81B-
Total Cash38.9M2.63B1%
Total Debt01.08B-
FUNDAMENTALS RATINGS
CRVO vs ONC: Fundamental Ratings
CRVO
ONC
OUTLOOK RATING
1..100
577
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
59
Fair valued
PROFIT vs RISK RATING
1..100
10069
SMR RATING
1..100
9894
PRICE GROWTH RATING
1..100
3548
P/E GROWTH RATING
1..100
65100
SEASONALITY SCORE
1..100
4739

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (45) in the Biotechnology industry is in the same range as ONC (59). This means that CRVO’s stock grew similarly to ONC’s over the last 12 months.

ONC's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as CRVO (100). This means that ONC’s stock grew similarly to CRVO’s over the last 12 months.

ONC's SMR Rating (94) in the Biotechnology industry is in the same range as CRVO (98). This means that ONC’s stock grew similarly to CRVO’s over the last 12 months.

CRVO's Price Growth Rating (35) in the Biotechnology industry is in the same range as ONC (48). This means that CRVO’s stock grew similarly to ONC’s over the last 12 months.

CRVO's P/E Growth Rating (65) in the Biotechnology industry is somewhat better than the same rating for ONC (100). This means that CRVO’s stock grew somewhat faster than ONC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRVOONC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
86%
Bearish Trend 12 days ago
77%
Momentum
ODDS (%)
Bearish Trend 12 days ago
88%
Bullish Trend 12 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 12 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
90%
Bullish Trend 12 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
80%
Advances
ODDS (%)
Bullish Trend 21 days ago
81%
Bullish Trend 20 days ago
76%
Declines
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 26 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
90%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ONC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CRVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVO has been loosely correlated with TCRX. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVO jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
-1.13%
TCRX - CRVO
36%
Loosely correlated
+1.40%
LVTX - CRVO
28%
Poorly correlated
+2.33%
ADCT - CRVO
24%
Poorly correlated
+6.00%
IPSC - CRVO
24%
Poorly correlated
-0.28%
ONC - CRVO
24%
Poorly correlated
+0.88%
More

ONC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ONC has been loosely correlated with ZLAB. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if ONC jumps, then ZLAB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONC
1D Price
Change %
ONC100%
+0.88%
ZLAB - ONC
49%
Loosely correlated
-2.39%
RGNX - ONC
33%
Poorly correlated
-5.84%
AUTL - ONC
32%
Poorly correlated
+5.10%
ROIV - ONC
31%
Poorly correlated
-1.30%
DNLI - ONC
31%
Poorly correlated
-1.29%
More